![Amanda Cray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amanda Cray
Investor Relations Kontakt bei
FUSN PHAR
Profil
Amanda Cray currently works as Senior Director-IR & Corporate Communications at Fusion Pharmaceuticals, Inc. and as Head-Investor Relations at Autolus Therapeutics Plc since 2024.
Former roles include Associate Director-IR & Corporate Communications at Aegerion Pharmaceuticals, Inc. from 2012 to 2019, Director-IR & Corporate Communications at Novelion Therapeutics, Inc. from 2016 to 2019, Senior Account Executive at LaVoie Strategic Communications Group, Inc., Associate at Sharon Merrill Associates, Inc., and Account Manager at Harron & Associates, Inc. Education includes graduate studies at Boston University and undergraduate studies at the University of New Hampshire.
Aktive Positionen von Amanda Cray
| Unternehmen | Position | Beginn |
|---|---|---|
| FUSN PHAR | Investor Relations Kontakt | - |
| AUTOLUS THERAPEUTICS PLC | Investor Relations Kontakt | 01.11.2024 |
Ehemalige bekannte Positionen von Amanda Cray
| Unternehmen | Position | Ende |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.07.2019 |
| NOVELION THERAPEUTICS INC. | Investor Relations Kontakt | 01.07.2019 |
Sharon Merrill Associates, Inc.
 Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services | Corporate Officer/Principal | - |
Harron & Associates, Inc. | Corporate Officer/Principal | - |
LaVoie Strategic Communications Group, Inc.
 LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services Provides strategic communications programs, strategy and brand positioning services | Corporate Officer/Principal | - |
Ausbildung von Amanda Cray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
38
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LaVoie Strategic Communications Group, Inc.
LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services Provides strategic communications programs, strategy and brand positioning services | Commercial Services |
Sharon Merrill Associates, Inc.
Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services | Commercial Services |
Harron & Associates, Inc. | |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Wählen Sie MarketScreener 
